Rain Enhancement Technologies Holdco, Inc. Class A Common Stock (RAIN NASDAQ) stock market data APIs
$1.9112
0.1(5.5%)
as of March 25, 2025
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock Financial Data Overview
Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology. The company is based in Naples, Florida. Rain Enhancement Technologies Holdco, Inc. operates as a subsidiary of Rainwater, LLC.
Prev. Close
1.8075
Open
1.9112
High
1.9917
Low
1.6676
52 wk Range
1.4342-13.4753
Market Cap
15 628 K
Shares Outstanding
7 529 K
EPS
-0.1062
Beta
-0.028
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rain Enhancement Technologies Holdco, Inc. Class A Common Stock data using free add-ons & libraries
Get Rain Enhancement Technologies Holdco, Inc. Class A Common Stock Fundamental Data
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -3 372 568
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Rain Enhancement Technologies Holdco, Inc. Class A Common Stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2024-09-30
- EPS/Forecast: NaN
Get Rain Enhancement Technologies Holdco, Inc. Class A Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock News
New
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on ...
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentr...
Rain Oncology Inc: Please contact the Portnoy Law Firm to recover your losses; September 12, 2023 deadline.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rain Oncology Inc. (“Rain”...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. (RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFI...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
